Benjamin Maasoumy - Concepedia

Author

Benjamin Maasoumy

Also Known As

Astrid Petersmann, B Maasoumy, B. Maasoumy, Benjamin Maasoumy, Carsten Meyer, D Bettinger, Dominik Bettinger, Martina Sterneck

390

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover German Center for Infection Research Centre for Individualised Infection Medicine Goethe University Frankfurt Helmholtz Centre for Infection Research

About

Benjamin Maasoumy is an author at Medizinische Hochschule Hannover specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	773
2	Health Sciences	4	4	126
3	Cell Biology	1	1	32
4	Epidemiology	1	1	141
5	Health Policy	1	1	26

Benjamin Maasoumy

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Prothrombotic immune thrombocytopenia after COVID-19 vaccination Andreas Tiede, Ulrich J. Sachs, Andreas Czwalinna, Blood	2021	174
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D Benjamin Maasoumy, Steffen B. Wiegand, Jerzy Jaroszewicz, Clinical Microbiology and Infection Hepatitis DViral HepatitisImmunologyHepatitis BHepatitis	2015	141
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B Christoph Höner zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, The Journal of Infectious Diseases Hbsag LossImmunologyHepatitis BPathologyImmunotherapy	2016	136
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels Milan J. Sonneveld, Shao‐Ming Chiu, Jun Yong Park, Journal of Hepatology	2022	114
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) Milan J. Sonneveld, Jun Yong Park, Apichat Kaewdech, Clinical Gastroenterology and Hepatology	2020	101
Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting Benjamin Maasoumy, Kerstin Port, Antoaneta A. Markova, PLoS ONE	2013	99
Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Clinical Infectious Diseases	2015	93
Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection Elmira Aliabadi, Melanie Urbanek‐Quaing, Benjamin Maasoumy, Gut	2021	91
Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis Tammo Lambert Tergast, Markus Kimmann, H. Laser, Alimentary Pharmacology & Therapeutics	2019	68
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens Benjamin Maasoumy, Johannes Vermehren, Martin‐Walter Welker, Journal of Hepatology Viral PersistenceViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitis	2016	65

Page 1